Patient-reported outcomes from a phase HI multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing alter chemotherapy: Cancer Oesophagus Gefitinib (COG)

Autor:	Dutton, S, Blazeby, J, Petty, R, Mansoor, W, Thompson, J, Harrison, M, Abbas, H, Dahle-Smith, A, Chatterjee, A, Falk, S, Garcia-Alonso, A, Fyfe, D, Hubner, R, Gamble, T, Peachey, L, Harvey, C, Julier, P, Jankowski, J, Midgley, R, Ferry, DR, Grp, C
Rok vydání:	2013
Zdroj:	JOURNAL OF CLINICAL ONCOLOGY. 31(4)
ISSN:	0732-183X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::11d4d3bb5aa925c2574b47b90fcc66b4 http://ora.ox.ac.uk/objects/uuid:92536180-a53c-4324-9594-d7cb15ec45d8 Zobrazit plný text záznamu